| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10764578 | Biochemical and Biophysical Research Communications | 2011 | 4 Pages |
Abstract
⺠Telmisartan was the strongest ARB for the reduction of BP in patients with essential hypertension. ⺠Telmisartan had a unique binding mode to the AT1 receptor due to its distal benzimidazole portion. ⺠Due to its “delta lock” structure, telmisartan may be superior to other ARBs in halting cardiovascular disease in patients with hypertension.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kazuki Ohno, Yasushi Amano, Hirotoshi Kakuta, Tatsuya Niimi, Shoji Takakura, Masaya Orita, Keiji Miyata, Hitoshi Sakashita, Makoto Takeuchi, Issei Komuro, Jitsuo Higaki, Masatsugu Horiuchi, Shokei Kim-Mitsuyama, Yutaka Mori, Ryuichi Morishita,